MRNAModerna
Moderna is a pioneer and leader in the field of mRNA medicine. 10-K, Item 1
- Employees
- 4,700
- Headquarters
- Cambridge, MA
- CEO
- Stephane Bancel
- Next results
- around Jan 11, 2027
Every trade in MRNA shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.
Bought on the market
$0
0 trades by 0 insiders
Sold on the market
$72.1M
17 trades by 5 insiders
| Date | Insider | Role | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Stephen Hoge | President | Sale (10b5-1) | -39,145 | 220.72 | 8.6M | 1,636,565 |
| Oct 14, 2026 | Stephen Hoge | President | Sale (10b5-1) | -38,774 | 213.47 | 8.3M | 1,599,708 |
| Oct 14, 2026 | Stephen Hoge | President | Sale (10b5-1) | -450 | 214.15 | 96K | 1,599,258 |
| Sep 15, 2026 | Stephen Hoge | President | Sale (10b5-1) | -40,281 | 146.07 | 5.9M | 1,562,029 |
| Sep 14, 2026 | Stephen Hoge | President | Sale (10b5-1) | -40,294 | 144.13 | 5.8M | 1,525,858 |
| Sep 10, 2026 | James M. Mock | Chief Financial Officer | Sale (10b5-1) | -19,836 | 134.49 | 2.7M | 74,375 |
| Sep 10, 2026 | James M. Mock | Chief Financial Officer | Sale (10b5-1) | -15,000 | 134.49 | 2.0M | 59,375 |
| Sep 1, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale (10b5-1) | -3,471 | 139.95 | 486K | 74,129 |
| Aug 5, 2026 | Stephane Bancel | Chief Executive Officer, Director | Sale (10b5-1) | -147,473 | 56.21 | 8.3M | 6,539,564 |
| Aug 5, 2026 | Stephane Bancel | Chief Executive Officer, Director | Sale (10b5-1) | -124,838 | 56.96 | 7.1M | 6,414,726 |
| Aug 5, 2026 | Stephane Bancel | Chief Executive Officer, Director | Sale (10b5-1) | -39,891 | 58.12 | 2.3M | 6,374,835 |
| Aug 5, 2026 | Stephane Bancel | Chief Executive Officer, Director | Sale (10b5-1) | -187,044 | 58.79 | 11.0M | 6,187,791 |
| Jul 15, 2026 | Stephen Hoge | President | Sale (10b5-1) | -53,336 | 67.60 | 3.6M | 1,483,848 |
| Jun 15, 2026 | Stephen Hoge | President | Sale (10b5-1) | -53,336 | 51.37 | 2.7M | 1,483,848 |
| Jun 4, 2026 | Shannon Thyme Klinger | Chief Legal Officer | Sale (10b5-1) | -3,471 | 50.00 | 174K | 67,468 |
| May 21, 2026 | Noubar Afeyan (indirect) | Director | Sale | -9,263 | 46.84 | 434K | 3,924 |
| May 15, 2026 | Stephen Hoge | President | Sale (10b5-1) | -53,336 | 48.40 | 2.6M | 1,477,997 |
From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).
Work on MRNA in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/MRNA/export.csv") into a cell.